Pemphigus—The Crux of Clinics, Research, and Treatment during the COVID-19 PandemicReview Published on 2021-10-282022-10-28 Journal: Biomedicines [Category] COVID-19, [키워드] approach autoantibody autoantigen Autoimmune disease Blister classical clinics COVID-19 COVID-19 infection desmoglein determine develop diagnostic discrepancy immunodermatology immunosuppressive effect lesion Manifestations mucosal other immunosuppressive agents Pathogenesis pathogenic autoantibody pathophysiological Patient pemphigus profile Proteins raised risk rituximab SARS-CoV-2 SARS-CoV-2 pandemic subtype Treatment use of corticosteroid vaccine response variant [DOI] 10.3390/biomedicines9111555 PMC 바로가기 [Article Type] Review
Real world evidence: Patients with refractory pemphigus treated with RituximabOriginal Research Paper Published on 2021-10-202024-09-04 Journal: Metabolism Open [Category] 대상포진, [키워드] autoimmune blistering disease biologic Efficacy Immunosuppression pemphigus rituximab Safety [DOI] 10.1016/j.metop.2021.100142 PMC 바로가기 [Article Type] Original Research Paper
Pemphigus Vulgaris After COVID-19: a Case of Induced AutoimmunityCovid-19 Published on 2021-05-272024-09-04 Journal: Sn Comprehensive Clinical Medicine [Category] 대상포진, [키워드] Autoimmunity COVID-19 emerging infections pemphigus SARS-CoV-2 viruses [DOI] 10.1007/s42399-021-00971-8 PMC 바로가기 [Article Type] Covid-19
Rituximab Therapy for Treatment of Pemphigus in Southeast AsiansOriginal Research Published on 2021-04-222024-09-04 Journal: Drug design, development and therapy [Category] 대상포진, [키워드] Anti-CD20 monoclonal antibody Asia autoimmune bullous pemphigus rituximab [DOI] 10.2147/DDDT.S306046 PMC 바로가기 [Article Type] Original Research
Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With Rituximab사례 보고서: 리툭시맙으로 치료받은 천포창 환자의 중증 COVID-19에서 완전하고 빠른 회복Case Reports Published on 2021-04-162022-09-12 Journal: Frontiers in Immunology [Category] MERS, 진단, [키워드] acute respiratory syndrome autoantibody Autoimmune autoimmune blistering disease Autoimmune disease B cell B-cell blistering caused Cell characterized clinician components condition corticosteroid treatment COVID-19 COVID-19 pandemic disease effective Immunosuppression induce Infection infections inflammatory phase involved management mucous membrane outcome pandemic Patient pemphigus raised risk rituximab RTX safety profile severe pulmonary disease susceptibility Therapies Topic Treatment [DOI] 10.3389/fimmu.2021.665522 PMC 바로가기 [Article Type] Case Reports
Rituximab as the treatment of pemphigus vulgaris in the COVID-19 pandemic era: A narrative reviewCOVID-19 대유행 시대의 심상성 천포창 치료제로서의 리툭시맙: 내러티브 리뷰Review Published on 2021-01-012022-09-12 Journal: Dermatologic therapy [Category] MERS, SARS, 진단, [키워드] adverse effect adverse outcomes anti-CD20 anti-CD20 therapy article Autoimmune blistering clinical study COVID-19 COVID-19 pandemic database disease drugs Evidence immunosuppressive immunosuppressive medications novel coronavirus disease pandemic Patient patients patients with COVID-19 pemphigus pemphigus vulgaris performed raised reported rituximab searched Seven shown therapy treated Treatment website [DOI] 10.1111/dth.14405 PMC 바로가기 [Article Type] Review
Can rituximab be used in the treatment of pemphigus vulgaris during the COVID-19 pandemic?COVID-19 범유행 기간 동안 심상성 천포창의 치료에 리툭시맙을 사용할 수 있습니까?Article Published on 2021-01-012022-09-12 Journal: Dermatologic therapy [Category] MERS, SARS, 진단, [키워드] B-cell Can CD20 Course COVID-19 COVID-19 infection COVID-19 pandemic Diagnosis disease course faculty group of disease independent lymphocyte male Mild monoclonal antibody no significant difference Patient pemphigus preventive measure rituximab target Treatment [DOI] 10.1111/dth.14647 PMC 바로가기 [Article Type] Article
Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases—Implications for Therapeutic ApproachesReview Published on 2020-12-072023-08-30 Journal: Cells [Category] E형 간염, [키워드] autoantibodies Autoimmunity B cells BAFF BLyS lupus erythematosus pemphigoid pemphigus skin Tertiary lymphoid structures [DOI] 10.3390/cells9122627 PMC 바로가기 [Article Type] Review
Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases천포창 사례에서 전신 스테로이드 및 대변-구강 배출 위험 및 SARS-CoV-2 전파 증가Article Published on 2020-11-012022-09-11 Journal: Clinics in dermatology [Category] SARS, 변종, [키워드] acquisition autoantibodies autoantibody Autoimmune blistering breach desmoglein disease integumentary system involved mucosal mucosal barrier mucous membranes Pathogenesis Pathogens pemphigus risk Shield steroid syndrome systemic therapeutic transmission of SARS-CoV-2 Treatment Usher syndrome variants virion vulgaris [DOI] 10.1016/j.clindermatol.2020.06.006 PMC 바로가기 [Article Type] Article
Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic reviewReview Article Published on 2020-07-072024-09-04 Journal: Dermatologic therapy [Category] 대상포진, [키워드] biologic Concomitant concurrent Corona virus COVID‐19 Cutaneous immunobullous immunomodulator immunosuppressive manifestation novel human coronavirus (SARS‐CoV‐2) pemphigoid pemphigus psoriasis psoriatic arthritis Simultaneous skin specific skin disease systematic review systemic drug [DOI] 10.1111/dth.13867 PMC 바로가기 [Article Type] Review Article